Lexagene-logo_srgb_1000px.jpg
LexaGene Successfully Completes Statement of Work for BioPharma Company
November 22, 2022 08:00 ET | LexaGene Holdings Inc
BEVERLY, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has...
Lexagene-logo_srgb_1000px.jpg
LexaGene Closes Secured Convertible Note Transaction
November 01, 2022 16:01 ET | LexaGene Holdings Inc
BEVERLY, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the...
Lexagene-logo_srgb_1000px.jpg
LexaGene Holdings Proposes to Amend Warrants Terms
October 27, 2022 17:18 ET | LexaGene Holdings Inc
BEVERLY, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized the...
Lexagene-logo_srgb_1000px.jpg
LexaGene Enters into Secured Convertible Note Agreement
October 24, 2022 08:00 ET | LexaGene Holdings Inc
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BEVERLY, Mass., Oct. 24, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings,...
Lexagene-logo_srgb_1000px.jpg
Large Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology Validation
October 20, 2022 07:45 ET | LexaGene Holdings Inc
BEVERLY, Mass., Oct. 20, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has...
Lexagene-logo_srgb_1000px.jpg
LexaGene Receives Signed Quote from Large Biopharma Company to Purchase a MiQLab System
October 13, 2022 07:45 ET | LexaGene Holdings Inc
BEVERLY, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has...
Lexagene-logo_srgb_1000px.jpg
LexaGene Announces MiQLab® System Sale to Veterinary Hospital in California
September 01, 2022 08:00 ET | LexaGene Holdings Inc
BEVERLY, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has...
Lexagene-logo_srgb_1000px.jpg
LexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be Declared
August 29, 2022 08:00 ET | LexaGene Holdings Inc
BEVERLY, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has...
Lexagene-logo_srgb_1000px.jpg
LexaGene’s MiQLab System Generates Leptospira Results in as Soon as 30 minutes using Isothermal Chemistry
August 24, 2022 08:00 ET | LexaGene Holdings Inc
BEVERLY, Mass., Aug. 24, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has...
Lexagene-logo_srgb_1000px.jpg
University of Pennsylvania’s School of Veterinary Medicine to Evaluate New Gastrointestinal Panel Using LexaGene’s MiQLab System
August 17, 2022 08:00 ET | LexaGene Holdings Inc
BEVERLY, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has...